A guest blog published by the Medicines and Healthcare products Regulatory Agency on 27 August 2026 set out Cari-Anne Quinn's views on health innovation in Wales. Quinn, chief executive of Life Sciences Hub Wales, argued that innovation should target where systems are stuck and delays occur, and that ideas must move beyond individual pilots into wider use.

The blog cited Cardiff and Vale's Rapid Diagnosis Clinic, which it said reduced average referral-to-diagnosis times from 84.2 days to 6.2 days in its first year. It also described an AI-driven waiting-list validation tool co-developed by Betsi Cadwaladr University Health Board and digital health company EBO, which used SMS and chatbot technology; during pilot phases, the blog said, it removed 6-7% of patients from waiting lists.

Quinn pointed to a partnership with Macmillan Cancer Support bringing together people with lived experience, NHS organisations, the Welsh Government, academia and the third sector. She said Wales' life sciences sector employs more than 13,000 people across approximately 300 companies and generates around £3.6 billion in annual turnover. The MHRA foreword described a new programme of MHRA Liaison Days intended to bring regulatory expertise closer to innovators in Wales.